Pin-nan C. Cheng
138 Sheng Li Road
Tainan, TNQ 70401, Taiwan
Tainan, TNQ 70401, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 113 publications
Correction: Clinical Relevancies of Sarcopenic Obesity in Patients with Metabolic Dysfunction‑Associated Fatty Liver Disease (MASLD).
Journal: Digestive diseases and sciences
Published: August 29, 2026
Survival impact of hepatitis C virus eradication in patients with or without active hepatocellular carcinoma: A nationwide cohort study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 03, 2025
Effects of Sofosbuvir/Velpatasvir Therapy on Extrahepatic Manifestations in Patients With Type 2 Diabetes and Chronic Hepatitis C: Insights From a Nationwide Hepatitis C Virus Registry in Taiwan.
Journal: The Kaohsiung journal of medical sciences
Published: April 08, 2025
Enhanced nuclear localization of small heterodimer partner in metabolic dysfunction-associated steatohepatitis.
Journal: JHEP reports : innovation in hepatology
Published: March 18, 2025
Long-term risk of depression and the impact of risk factors among chronic hepatitis C patients after successful antiviral therapy: A nationwide real-world Taiwanese cohort (T-COACH).
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: February 21, 2025
Impact of Hepatitis C Virus Clearance on Cardiovascular Risk: A Real-World Experience From the Nationwide Taiwan Hepatitis C Virus Registry.
Journal: The Kaohsiung journal of medical sciences
Published: February 13, 2025
Refining Risk Estimates of Colorectal Cancer in Steatotic Liver Disease: Insights on Methodological Challenges.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: February 12, 2025
Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trial.
Journal: The lancet. Gastroenterology & hepatology
Published: November 28, 2024
Posttreatment FIB-4 score change predicts hepatocellular carcinoma in chronic hepatitis C patients: Findings from the Taiwan hepatitis C registry program.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: November 11, 2024
Direct-acting antiviral therapy for patients with hepatitis C virus-related hepatocellular carcinoma: A nationwide cohort study.
Journal: Clinical and molecular hepatology
Published: November 10, 2024
Real-world efficacy and safety of universal 8-week glecaprevir/pibrentasvir in patients with chronic hepatitis C with early chronic kidney disease or pre-end-stage renal disease: Insights from a nationwide hepatisis C virus registry in Taiwan.
Journal: The Kaohsiung journal of medical sciences
Published: October 27, 2024
Last Updated: 09/26/2026